Q&A: CDK4/6i in Early BC
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Expert Answers to Clinician Questions

Released: August 05, 2021

Expiration: August 04, 2022

Javier Cortes
Javier Cortes, MD, PhD
Stephen Raffanti
Stephen Raffanti, MD, MPH
Sara M. Tolaney
Sara M. Tolaney, MD, MPH

Activity

Progress
1
Course Completed